A previous study reported that greater numbers of circulating bone marrow-derived stem cells correlated with increased serum EPO levels in patients with neovascular AMD and compared to corresponding measurements in patients with inactive AMD. The gene discussed is EPO; the disease is age-related macular degeneration.